Prognostic impact of estimated remnant-like particle cholesterol in patients with differing glycometabolic status: an observational cohort study from China

Does high estimated RLP-C level predict recurrent adverse events in patients with diabetes and NSTE-ACS treated with PCI?

Population

Patients with diabetes and non-ST-segment elevation acute coronary syndrome (NSTE-ACS) treated with percutaneous coronary intervention (PCI)

Intervention

High estimated remnant-like particle cholesterol (RLP-C) level

Outcome

Recurrent adverse events

Estimated RLP-C levels can serve as a prognostic marker for recurrent adverse events in diabetic patients with NSTE-ACS undergoing PCI.

High estimated RLP-C level is a significant predictor for recurrent adverse events in patients with diabetes and NSTE-ACS treated with PCI.

Bookmark

View Full Paper

Bookmark

View Full Paper

Cite This Study